ABBV · AbbVie Inc. · Executive Compensation
$255.00
+4.09 (+1.63%)
At close · Sep 10
Market Cap
$443.39B
Shares
1.77B
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Richard Gonzalez | CEO | $21,610,598 |
| Richard A. Gonzalez | Chairman of the Board and Chief Executive Officer | $21,610,598 |
| Laura J. Schumacher | — | $15,142,787 |
| Carlos Alban | — | $14,406,090 |
| Michael Severino | Vice Chairman and President | $9,508,448 |
| Robert Michael | CFO | $8,772,853 |
| Robert A. Michael | Executive Vice President, Chief Financial Officer | $8,772,853 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Richard Gonzalez | CEO | $21,283,587 |
| Richard A. Gonzalez | Chairman of the Board and Chief Executive Officer | $21,283,587 |
| Vice Chairman | External Affairs and Chief Legal Officer | $11,383,159 |
| Michael Severino | Vice Chairman and President | $8,607,359 |
| Robert Michael | CFO | $3,118,888 |
| Robert A. Michael | Executive Vice President, Chief Financial Officer | $3,118,888 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Richard A. Gonzalez | Chairman of the Board and Chief Executive Officer | $22,625,243 |
| Richard Gonzalez | CEO | $22,625,243 |
| Vice Chairman | External Affairs and Chief Legal Officer | $14,979,356 |
| Michael Severino | Vice Chairman and President | $8,395,276 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Glenn F. Tilton | director | Retired | 2025-05-13 |
| Richard A. Gonzalez | director | Retired | 2025-05-13 |
| Glenn F. Tilton | director | Retired | 2025-02-14 |
| Richard A. Gonzalez | Chairman | Retired | 2025-02-14 |
| Robert A. Michael | Chairman | Appointed | 2025-02-14 |
| David R. Purdue | Senior Vice President, Controller | Appointed | 2024-12-13 |
Key facts
CIK
1551152
CUSIP
00287Y109
13F (30d)
1059 filings
1001 filers
Visit website
Investor relations